Express Scripts Further Advances Transparency and Affordability for Consumers and Clients
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...
Read MoreMeet Eric Palmer, president and chief executive officer of Evernorth Health Services
Eric Palmer's career journey started with a summer internship at Cigna Healthcare. Today, he leads Evernorth Health Services, supporting employers and health plans in improving the health of their mem...
Read MoreInnovation in hemophilia drug development and cost-efficiency tools
As treatment for hemophilia evolves, data proves a good specialty pharmacy partner can help minimize waste and drive efficient practices.
Read MoreEvernorth partners with CarepathRx Health System Solutions to enhance specialty care for patients and drive physician performance
Evernorth is entering into a partnership with CarepathRx Health System Solutions to help hospitals, health systems and their physicians diversify their offerings, while enabling stronger patient conne...
Read MoreCarepathRx Health System Solutions and Evernorth Health Services Forge Strategic Partnership to Enhance Specialty Care for Patients
The partnership between CarepathRx Health System Solutions and Evernorth brings together diverse specialty and care expertise to improve, expand, and accelerate pharmacy care delivery for the growing ...
Read MoreHelping plans and patients get life-changing gene therapies
Gene therapies offer hope where none existed before, but health plans and employers need the right strategy to make these cutting-edge medications affordable and available.
Read MoreLeveraging biosimilars to drive savings and support patient access
By the end of 2023, 11 biosimilars for Humira will be available for patients living with inflammatory conditions, enabling lower costs for a drug class that currently represents nearly 25% of total dr...
Read MoreImmune checkpoint inhibitor medications: A game-changer in cancer treatments
A new report from the Evernorth Research Institute offers insights that can help health plans optimize cancer care.
Read MoreClinically Speaking: Gene Therapies: Million-Dollar Miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read MoreClinically Speaking: Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read More